FindTrial
Sign In

Clinicopathological features and prognosis of contralateral axillary lymph node metastasis in breast cancer

Clinicopathological features and prognosis of contralateral axillary lymph node metastasis in breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066449
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer with contralateral axillary lymph node metastasis

Interventions

Case group:N/A

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) SEER database data Inclusion criteria: 2004-2015, female, no age limit (18-90), diagnosed as: breast cancer contralateral axillary lymph node metastasis, unilateral cancer, primary cancer; breast cancer as the only cancer; staging: AJCC 6th edition The staging is stage I-III. (2) Multi-center data Inclusion criteria: female, no age limit, diagnosed as: breast cancer contralateral axillary lymph node metastasis, unilateral cancer, primary cancer; breast cancer as the only cancer; stage: AJCC 6th edition stage I-III; received surgery .

Exclusion criteria

Exclusion criteria: Exclusion criteria: no follow-up information

Design outcomes

Primary

MeasureTime frame
Overall survival rate;—

Countries

China

Contacts

Public ContactHou Lingmi

Affiliated Hospital of North Sichuan Medical College

houlingmi@163.com+86 13890798808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026